Clinical Relapse of Anti-AMPAR Encephalitis Associated with Recurrence of Thymoma

Intern Med. 2018 Apr 1;57(7):1011-1013. doi: 10.2169/internalmedicine.9682-17. Epub 2017 Dec 8.

Abstract

We report a rare case of anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis presenting clinical relapse in association with recurrence of thymoma. Anti-AMPAR encephalitis is an autoimmune-mediated neurological disease, frequently accompanied by the presence of neoplasms, thus comprising the spectrum of paraneoplastic syndrome. A patient had been in remission for 34 months showed clinical relapse 3 months after the detection of recurrent thymoma. Clinical relapse of anti-AMPAR encephalitis after the recurrence of an initially detected neoplasm has not been previously reported. Our case therefore highlights the pathogenic relevance of specific tumor antigens as a trigger of anti-AMPAR antibody production and induction of the disease.

Keywords: anti-AMPAR encephalitis; paraneoplastic syndrome; thymoma.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Adult
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / diagnostic imaging
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / drug therapy*
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / etiology*
  • Chronic Disease / therapy*
  • Female
  • Humans
  • Neoplasm Recurrence, Local / etiology*
  • Thymoma / complications*
  • Thymus Neoplasms / complications*
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones